Established in 1991, the clinic is an outpatient facility that successfully treats skin-related conditions and diseases, ranging from fine lines and wrinkles to skin cancer.
We focus exclusively on laser applications and cutting-edge technology.
- To provide unique personalized treatments in a welcoming environment;
- To discover new therapeutic applications of laser light for treating specific medical conditions through research on the effects of light on the skin’s molecules and cells as well as on the body;
- To inform and educate the scientific community (physicians, researchers and students) and patients on light-based treatments.
DR. DANIEL BAROLET, MORE THAN JUST A PHYSICIAN…
Dr. Barolet is also a pioneer, a researcher and an innovator who has gained international recognition for his expertise.
A graduate from McGill and Laval universities, and Université de Montréal, Dr. Daniel Barolet has been specializing in dermatological laser therapy since 1991.
A committed educator, Dr. Barolet served as clinical supervisor (laser portion) at Université de Montréal from 1992 to 2000. He has also taught countless training workshops and authored many scientific articles on light-based dermatology treatments. In addition, he is frequently invited as a guest lecturer to national and international conventions to present his research findings and clinical results. Dr. Barolet is also Adjunct Professor at McGill University.
In addition, for more than twenty-five years, an important part of his work has been devoted to research and development through his Skin Optics Research Laboratory, RoseLab.
His work in research has led to numerous technological innovations, patents and new treatment methods, mainly focused on laser-skin interactions, LED therapy and photobiomodulation and photodynamic therapy (PDT).
Dr. Barolet is always seeking new therapeutic applications to treat his patients more efficiently. He has focused an essential part of his career on research in an ongoing effort to gain further scientific knowledge of lasers and laser-based technologies for dermatological use.
Dr. Barolet’s clinic is also an innovation center focusing on the future of photodermatology.
For more than 25 years, the clinic has offered laser treatments to over 7,000 patients annually.
Dr. Barolet founded the first clinic exclusively dedicated to laser skin applications in Canada in 1992. Five years later, he founded the RoseLab, Canada’s first skin optics research laboratory. He then developed a portable photoepilation laser system – the first of its kind – using high-power diodes. In 2001, he launched the photobiomodulation (low-intensity light therapy) project.
Patents for the skin
A series of innovative patents related to light-based treatment methods and devices for the skin followed.
Dr. Barolet then went on to discover light pulse codes, communicating with the skin in a “Morse code way,” which has led to revolutionary patented concepts:
- Photorejuvenation (compensation for the loss of collagen to reverse the signs of ageing)
- Photoprevention (prevention against sun exposure, hyperpigmentation and scarring)
- Photopreparation (increases the effectiveness of creams, in synergy with the therapeutic properties of light)
Using the patented Lumiphase technology, RoseLab created a customized 688nm wavelength LED platform dedicated to photodynamic therapy (PDT) for a Vancouver company (QLT Inc.).
In addition, RoseLab has designed a high-power LED device (Lumiphase ™) for the US Navy (San Diego) to accelerate the wound healing process and the minimization of scarring for soldiers returning from mission in the Middle East (Iraq / Afghanistan).
THE FUTURE OF DERMATOLOGICAL LASER TREATMENTS
Dr. Barolet is currently working on the use of multi-wavelength LED light to release local and systemic skin nitric oxide (NO) via a large area LED bed. The distant effects of NO in the human body are numerous (see figure).
Read our latest article about this treatment:
LIGHT-INDUCED nitric oxide release in the SKIN BEYOND UVA and blue light: RED & near-infrared wavelengths (Barolet AC, Litvinov IV, Barolet D., Nitric Oxide. 2021 Sep 15:S1089-8603(21)00091-4. doi: 10.1016/j.niox.2021.09.003. Epub ahead of print. PMID: 34536586.)